Previous Article | Next Article ![]()
Infect. Immun., Feb 1997, 645-650, Vol 65, No. 2
MP Bos, D Hogan and RJ Belland
Experimental infections of human male volunteers with Neisseria gonorrhoeae
have provided valuable insights into the early stages of gonorrheal
disease. Bacterial variants expressing outer membrane opacity (Opa)
proteins appear to be selected from the inoculum during a period in which
total recoverable numbers of bacteria decrease rapidly. This apparent
survival advantage occurs simultaneously with the onset of an inflammatory
response, characterized by local production of interleukin 6 (IL-6) and
IL-8 and the appearance of leukocytes in urine. Since the inflammatory
response may also result in the presence of serum factors on the mucosal
surface, we investigated the possibility that killing in normal human serum
(NHS) leads to the selection of Opa+ variants. We therefore studied killing
of separate populations and mixtures of Opa- and Opa+ N. gonorrhoeae MS11mk
in NHS. Expression of an Opa protein conferred a survival advantage upon
the organism; i.e., the Opa+ variants were more serum resistant than their
isogenic Opa- counterparts, resulting in a selection for Opa+ phenotypes
when a mixture of Opa+ and Opa- gonococci (GC) was exposed to submaximal
doses of NHS. This selection was observed in three different
lipooligosaccharide (LOS) backgrounds, indicating that it was not due to a
difference in LOS expression between Opa- and Opa+ phenotypes. Incubation
in NHS of sialylated GC resulted in a similar selection for Opa+ variants.
The presence of normal human urine during the serum killing assay had no
effect on the selection phenomenon but drastically depleted NHS of
bactericidal activity, which was found to be at least partly due to
complement inhibition. The results suggest that serum killing may
contribute to the transition from Opa- to Opa+ phenotypes during the early
stages of infection of the male urethra.
Copyright © 1997, American Society for Microbiology
Selection of Opa+ Neisseria gonorrhoeae by limited availability of normal human serum
Laboratory of Microbial Structure and Function, National Institute of Allergy and Infectious Diseases, Hamilton, Montana 59840, USA. Martine_Bos@nih.gov
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|